BCWORLD Financial Statements From 2010 to 2025

200780 Stock  KRW 4,720  35.00  0.74%   
BCWORLD PHARM financial statements provide useful quarterly and yearly information to potential BCWORLD PHARM Co investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on BCWORLD PHARM financial statements helps investors assess BCWORLD PHARM's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting BCWORLD PHARM's valuation are summarized below:
BCWORLD PHARM Co does not today have any fundamental signals for analysis.
Check BCWORLD PHARM financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among BCWORLD PHARM's main balance sheet or income statement drivers, such as , as well as many indicators such as . BCWORLD financial statements analysis is a perfect complement when working with BCWORLD PHARM Valuation or Volatility modules.
  
This module can also supplement various BCWORLD PHARM Technical models . Check out the analysis of BCWORLD PHARM Correlation against competitors.

BCWORLD PHARM Co Company Current Valuation Analysis

BCWORLD PHARM's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.

Enterprise Value

 = 

Market Cap + Debt

-

Cash

More About Current Valuation | All Equity Analysis

Current BCWORLD PHARM Current Valuation

    
  232.12 B  
Most of BCWORLD PHARM's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, BCWORLD PHARM Co is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
Competition

In accordance with the recently published financial statements, BCWORLD PHARM Co has a Current Valuation of 232.12 B. This is much higher than that of the Pharmaceuticals sector and significantly higher than that of the Health Care industry. The current valuation for all Republic of Korea stocks is notably lower than that of the firm.

BCWORLD PHARM Fundamental Drivers Relationships

Comparative valuation techniques use various fundamental indicators to help in determining BCWORLD PHARM's current stock value. Our valuation model uses many indicators to compare BCWORLD PHARM value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across BCWORLD PHARM competition to find correlations between indicators driving BCWORLD PHARM's intrinsic value. More Info.
BCWORLD PHARM Co is number one stock in return on equity category among its peers. It also is number one stock in return on asset category among its peers reporting about  0.03  of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for BCWORLD PHARM Co is roughly  31.70 . Comparative valuation analysis is a catch-all model that can be used if you cannot value BCWORLD PHARM by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for BCWORLD PHARM's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.

About BCWORLD PHARM Financial Statements

BCWORLD PHARM stakeholders use historical fundamental indicators, such as BCWORLD PHARM's revenue or net income, to determine how well the company is positioned to perform in the future. Although BCWORLD PHARM investors may analyze each financial statement separately, they are all interrelated. For example, changes in BCWORLD PHARM's assets and liabilities are reflected in the revenues and expenses on BCWORLD PHARM's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in BCWORLD PHARM Co. Please read more on our technical analysis and fundamental analysis pages.

Pair Trading with BCWORLD PHARM

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if BCWORLD PHARM position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in BCWORLD PHARM will appreciate offsetting losses from the drop in the long position's value.
The ability to find closely correlated positions to BCWORLD PHARM could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace BCWORLD PHARM when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back BCWORLD PHARM - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling BCWORLD PHARM Co to buy it.
The correlation of BCWORLD PHARM is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as BCWORLD PHARM moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if BCWORLD PHARM moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for BCWORLD PHARM can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Other Information on Investing in BCWORLD Stock

BCWORLD PHARM financial ratios help investors to determine whether BCWORLD Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in BCWORLD with respect to the benefits of owning BCWORLD PHARM security.